AI Buyer Insights:

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Michelin, an e2open customer evaluated Oracle Transportation Management

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Michelin, an e2open customer evaluated Oracle Transportation Management

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

European Medicines Agency Data, Technology Stack, and Enterprise Applications
Content Management
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Google Legacy Google Cloud Document AI Content Management Content Management n/a 2025 2025
In 2025, the European Medicines Agency implemented Google Cloud Document AI for Content Management. The deployment centralized document intake for regulatory submissions, clinical study dossiers, and committee materials into a searchable, structured content repository to support regulatory review workflows. Google Cloud Document AI was configured for document ingestion, optical character recognition, entity extraction, automated classification, and metadata tagging to enable structured review workflows. Custom parsers and extraction pipelines were applied to normalize clinical endpoints, study identifiers, and regulatory references, and to populate indexed fields for downstream assessment and retrieval. The solution was provisioned as a cloud native service within the agency's Google Cloud environment, with role based access controls, audit logging, and encryption controls aligned to regulatory compliance needs. Operational coverage targeted regulatory review teams, clinical assessment committees, and dossier management functions across the agency, with APIs exposed for programmatic retrieval and export to internal case management processes. EMA's committee accepted AIM-NASH for use in clinical trials in 2025, increasing the demand for consistent, machine readable documentation to support evidence review and AI tool validation. Google Cloud Document AI was positioned to support that need by automating structured data capture and classification for Content Management, enabling reviewers to surface relevant trial evidence with maintained traceability and governance.
IaaS
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
IBM Legacy IBM Cloud (formerly IBM Bluemix and IBM SoftLayer) Application Hosting and Computing Services IaaS n/a 2014 2014
IT Decision Makers and Key Stakeholders at European Medicines Agency
First Name Last Name Title Function Department Email Phone
No data found
Apps Being Evaluated by European Medicines Agency Executives
Date Company Status Vendor Product Category Market
No data found
FAQ - APPS RUN THE WORLD European Medicines Agency Technographics

European Medicines Agency is a Government organization based in Netherlands, with around 1013 employees and annual revenues of $599.0 million.

European Medicines Agency operates a diverse technology stack with applications such as Google Cloud Document AI and IBM Cloud (formerly IBM Bluemix and IBM SoftLayer), covering areas like Content Management and Application Hosting and Computing Services.

European Medicines Agency has invested in cloud applications and AI-driven platforms to optimize efficiency and growth, collaborating with vendors such as Google and IBM.

European Medicines Agency recently adopted applications including Google Cloud Document AI in 2025 and IBM Cloud (formerly IBM Bluemix and IBM SoftLayer) in 2014, highlighting its ongoing modernization strategy.

APPS RUN THE WORLD maintains an up-to-date database of European Medicines Agency’s key decision makers and IT executives, available to Premium subscribers.

Our research team continuously updates European Medicines Agency’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.

Subscribe to APPS RUN THE WORLD to access the complete European Medicines Agency technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.